logo
How did life survive 'Snowball Earth'? In ponds, study suggests

How did life survive 'Snowball Earth'? In ponds, study suggests

Yahoo19-06-2025
Earth has not always been so hospitable to live. During several ice ages, the planet's surface was almost completely frozen over, creating what has been dubbed "Snowball Earth".
Liquid water appears to be the most important ingredient for life on any planet, raising the question: how did anything survive such frosty, brutal times?
A group of scientists said Thursday that they had found an astonishing diversity of micro-organisms in tiny pools of melted ice in Antarctica, suggesting that life could have ridden out Snowball Earth in similar ponds.
During the Cryogenian Period between 635 and 720 million years ago, the average global temperature did not rise above -50 degrees Celsius (-58 Fahrenheit). The climate near the equator at the time resembled modern-day Antarctica.
Yet even in such extreme conditions, life found a way to keep evolving.
Fatima Husain, the lead author of a new study published in Nature Communications, told AFP there was evidence of complex life forms "before and after the Cryogenian in the fossil record".
"There are multiple hypotheses regarding possible places life may have persisted," said Husain, a graduate student at the Massachusetts Institute of Technology.
Perhaps it found shelter in patches of open ocean, or in deep-sea hydrothermal vents, or under vast sheets of ice.
The tiny melted ice pools that dotted the equator were another proposed refuge.
These ponds could have been oases for eukaryotes, complex organisms that eventually evolved into multicellular life forms that would rise to dominate Earth, including humans.
- Could aliens be hiding in ponds? -
Melted ice ponds still exist today in Antarctica, at the edges of ice sheets.
In 2018, members of a New Zealand research team visited the McMurdo ice shelf in east Antarctica, home to several such pools, which are only a few metres wide and less a metre deep.
The bottom of the ponds are lined with a mat of microbes that have accumulated over the years to form slimy layers.
"These mats can be a few centimetres thick, colourful, and they can be very clearly layered," Husain said.
They are made up of single-celled organisms called cyanobacteria that are known to be able to survive extreme conditions.
But the researchers also found signs indicating there were eukaryotes such as algae or microscopic animals.
This suggests there was surprising diversity in the ponds, which appears to have been influenced by the amount of salt each contained.
"No two ponds were alike," Husain said. "We found diverse assemblages of eukaryotes from all the major groups in all the ponds studied."
"They demonstrate that these unique environments are capable of sheltering diverse assemblages of life, even in close proximity," she added.
This could have implications in the search for extraterrestrial life.
"Studies of life within these special environments on Earth can help inform our understanding of potential habitable environments on icy worlds, including icy moons in our Solar System," Husain said.
Saturn's moon Enceladus and Jupiter's Europa are covered in ice, but scientists increasingly suspect they could be home to simple forms of life, and several space missions have been launched to find out more about them.
ber/dl/js
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Implantable Device Shows Promise for Preventing Hypoglycemia
Implantable Device Shows Promise for Preventing Hypoglycemia

Medscape

time4 hours ago

  • Medscape

Implantable Device Shows Promise for Preventing Hypoglycemia

A new minimally invasive device, while still in development, could become a lifesaver for individuals with diabetes who experience hypoglycemia, according to researchers at the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts. In a paper published in Nature Biomedical Engineering , Siddharth R. Krishnan, PhD, now an assistant professor of electrical engineering at Stanford University in Stanford, California, and colleagues at MIT described a wireless device implanted into diabetic mice that prevented hypoglycemia. The implant weighs < 2 g and is only 3 cm3 in size; it remains under the skin and releases a powdered version of glucagon automatically when a sensor detects low blood sugar. The researchers simulated hypoglycemia in the mice, and the release of the dry glucagon was triggered wirelessly. Measurements showed a rapid rise in blood glucose soon after the release, with a peak of 30 mg/dL after no more than 15 minutes. A second set of studies replicated conditions that often drive hypoglycemia, such as missed meals and automated infusions from insulin pumps. Similarly, the use of the wireless release of dry glucagon resulted in blood glucose concentrations above the threshold for hypoglycemia (average concentration of 80 mg/dL) within the first hour after the release. An area under the curve analysis over 30 minutes after release showed significant changes in the glucose group compared with the control group who received lactose. 'A Pathway to Emergency Rescue' 'Glucagon is widely administered as an emergency rescue drug for patients suffering acute hypoglycemia, particularly in the context of type 1 diabetes,' corresponding author Daniel Anderson, PhD, a professor at the Koch Institute for Integrative Cancer Research at MIT, told Medscape Medical News . Glucagon's short half-life and low stability in solution has made development of pump systems a challenge, he said. By contrast, 'Dry powder versions of glucagon offer long-term stability but are difficult to deliver,' he said. 'An implantable device that can respond to hypoglycemia and release dry powder glucagon potentially offers a pathway to emergency rescue from hypoglycemia events without the need for patient intervention,' Anderson said. The early impact of the dry power was unexpected, Anderson said. 'The glucagon in our system is a dry powder that we designed to dissolve directly in biofluid, and the timeline for this dissolution and subsequent availability of the drug in circulation was an open question when we started this project,' he noted. 'The fact that we saw biological activity within 5 minutes of drug release was an important result in this context, and not one that we predicted.' Although the device is not ready for human use, the size and longevity are key questions for adoption in clinical practice, Anderson told Medscape Medical News . 'We are working on miniaturizing the device, so it is compatible with minimally invasive insertion techniques, and with a sufficient number of doses to provide protection from acute hypoglycemia for multiple years,' he said. 'So far, we have validated the device in preclinical small animal models.' Simultaneously miniaturizing the system and optimizing the dose and longevity in large animal models are the next steps for research, he added. Unmet Need for Glycemic Control 'Hypoglycemia and fear of hypoglycemia remains major barriers to optimal glycemic control for those with diabetes,' said Andrew Kraftson, MD, a specialist in endocrinology and internal medicine at the University of Michigan, Ann Arbor, Michigan, in an interview. 'Glucagon emergency delivery devices have advanced and become more user friendly but will not work if not available or expired. Liquid glucagon presents numerous challenges and is not yet commercially available for dual hormone insulin pump use,' said Kraftson, who was not involved in the research. 'Dual hormone pumps that are being studied or have been approved in Europe are large/bulky, may require two CGM [continuous glucose monitoring] sensors, and may require glucagon to be refilled more frequently than insulin, so a nonliquid, implantable device could avoid some of the obstacles posed by liquid glucagon,' Kraftson noted. However, more research is needed on the logistics of human implementation of the glucagon delivery device tested in the current study, Kraftson told Medscape Medical News . Questions include how the device would be implanted; how many doses the reservoir would hold; and how often, on average, it would need to be changed, he said. Other factors include how cumbersome this device might be for humans, potential risks for irritation or infection, and options for manual delivery in the event of a malfunctioning CGM or signal challenges in device communication, he said. 'Ideally, glucagon use for patients with diabetes would expand beyond emergency rescue,' Kraftson added. 'Reducing or even holding insulin is sometimes insufficient to avoid hypoglycemia, particularly rapid onset.' 'Additionally, eating carbohydrates to prevent or treat hypoglycemia is not ideal given the risk of subsequent overcorrection/hyperglycemia and weight gain; therefore, more frequent, sensor/algorithm-based use of glucagon can more effectively achieve stable glucose levels and help avoid the 'rollercoaster,'' he said. The small size of the device in the current study may limit its ability to participate in the larger mission of glucose management but could certainly still play an important role in hypoglycemia reduction, he noted. This study was funded by the Leona M. and Harry B. Helmsley Charitable Trust, the National Institutes of Health, a JDRF postdoctoral fellowship, and the National Institute of Biomedical Imaging and Bioengineering. Anderson and several coauthors reported being inventors on a patent application relevant to the technology described in this study but had no other financial conflicts of interest.

Scientists make startling discovery after analyzing historic photos of Antarctic ice shelves: 'An unambiguous signal'
Scientists make startling discovery after analyzing historic photos of Antarctic ice shelves: 'An unambiguous signal'

Yahoo

time14 hours ago

  • Yahoo

Scientists make startling discovery after analyzing historic photos of Antarctic ice shelves: 'An unambiguous signal'

Scientists make startling discovery after analyzing historic photos of Antarctic ice shelves: 'An unambiguous signal' They could have missed it — a black-and-white aerial image taken back in 1966. The photographer is imagined to have been a member of the U.S. Navy who was likely mapping the Antarctic landscape. But, years later, a few researchers noticed something unusual. That frozen frame seemed to show the Wordie Ice Shelf giving way. The old photo turned out to be a major clue, one that could reshape our understanding of Antarctica's melting crisis and show why ignoring it could cost us. What's happening? Researchers at the University of Copenhagen, the institution shared in a release, compared those vintage photos to newer satellite images. What they found was quiet but alarming: The Wordie Ice Shelf hadn't just melted from the surface — it had been worn down from beneath. Warmer ocean waters, they deduced, had slipped under the ice, slicing into it from the inside out. With the team's findings published in Nature Communications in April, corresponding author Mads Dømgaard explained in the university's release, "We have identified several signs of incipient ice shelf collapse that we expect will be observed in other ice shelves, but perhaps more importantly, the dataset has given us a multitude of pinning points that can reveal how far advanced a collapse is. It's a completely new tool." Dømgaard says the resource could be used to assess shelves that could collapse or are already collapsing. Co-author Anders Anker Bjørk added that they've found the process of "ice shelf collapse may be slower than we thought." But Bjørk also strongly cautioned, " … this longer process will make it harder to reverse the trend once it has started. This is an unambiguous signal to prioritise halting greenhouse gas emissions now rather than sometime in the future." Why does it matter? Wordie wasn't huge to start — losing it has bumped sea levels by only millimeters — but it has given scientists a look into the future. If bigger ice shelves, such as Ross or Ronne, crumble, the chain reaction could be a lot worse. These shelves currently provide a stabilizing force, and once they break down, it could be difficult to prevent further damage. That's why tools that might help researchers spot the signs of collapse earlier on could really matter. They might buy us more time — and offer stronger motivation to make a change. Do you think our power grid needs to be upgraded? Definitely Only in some states Not really I'm not sure Click your choice to see results and speak your mind. What can be done? Research like this in-depth look at the Wordie Ice Shelf can encourage more effective mitigation and adaptation efforts. As Bjørk noted, the team's findings underscore the urgency with which governments and coalitions need to reduce the amount of heat-trapping, ice-melting pollution in our atmosphere. They could also help state officials and community advocates better prepare to withstand the effects of rising sea levels by taking actions like updating flood guidance, reworking zoning ordinances, and relocating and strengthening critical infrastructure. But maybe these activities don't fall under your personal purview? Individual choices can still stack up — especially when organized en masse. Residents can organize support for policies that lower emissions, ask local officials how they're preparing for sea level rise, and use clean energy options whenever available. That photo sat, seemingly untouched, for decades. But it captured something big. And committed people took it to the next step. What happens next — that's still up to us. Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet. Solve the daily Crossword

World's first sound-powered microscope sees 5x deeper into brain without altering cells
World's first sound-powered microscope sees 5x deeper into brain without altering cells

Yahoo

timea day ago

  • Yahoo

World's first sound-powered microscope sees 5x deeper into brain without altering cells

For decades, scientists have pushed the limits of microscopy to capture sharper and deeper views of the brain. Traditional light-based systems can map the cortex in detail but struggle to reach deeper regions like the hippocampus without losing resolution. The challenge is even greater when imaging molecular activity inside single cells, which is an essential step in understanding brain function and diseases. MIT scientists and engineers have now built a microscope that overcomes this barrier by combining ultrafast light pulses with sound detection. The system can image at depths more than five times greater than existing methods without using dyes, chemicals, or genetic modification. Researchers believe it could transform neuroscience research and surgical applications. Seeing deeper into the brain The study shows the system can detect NAD(P)H, a molecule linked to cell metabolism and neuronal activity, through dense brain samples. Tests included a 1.1 millimetre thick human stem cell-derived cerebral organoid and a 0.7 millimetre slice of mouse brain tissue. 'That's when we hit the glass on the other side,' said W. David Lee, the postdoctoral researcher who designed the system, explaining that the samples were not large enough to push the technology's true limits. The device uses a three-photon excitation method, firing ultrashort light bursts at triple the molecule's normal absorption wavelength. These longer wavelengths scatter less and penetrate deeper into tissue. Most of the absorbed energy creates a rapid, microscopic thermal expansion inside the cell, generating sound waves. A sensitive ultrasound microphone detects these waves, and software turns them into sharp images. This process is called three-photon photoacoustic imaging. Merging advanced imaging techniques The team combined three-photon excitation, photoacoustic detection, and label-free imaging into a platform they call 'Multiphoton-In and Acoustic-Out.' This setup allows precise molecular detection without altering the tissue. The system can also identify other molecules, such as GCaMP, a calcium indicator used to track neural activity. Additionally, 'third-harmonic generation' imaging maps cellular structures, giving structural and molecular detail in the same scan. Co-lead author Tatsuya Osaki from The Picower Institute said the aim was to combine advanced techniques into one efficient process. This capability could help study conditions where NAD(P)H levels change, including Alzheimer's disease, Rett syndrome, and seizures. Because it works without labels, it could also guide brain surgeries by mapping activity in real time. The next goal is to test the system in living animals. In this case, both the light source and microphone will need to be on the same side of the tissue instead of opposite sides. Lee expects the system could image up to 2 millimetres deep in live brains. 'In principle it should work,' he said. Lee's earlier work through Precision Healing Inc. showed that NAD(P)H imaging can guide wound treatment. Now, the same approach may prove valuable for neurosurgery and brain research. The project was funded by the National Institutes of Health, the Simon Center for the Social Brain, The Picower Institute, and other sources. The study is published in the journal Light: Science and Applications. Solve the daily Crossword

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store